Department of Epidemiology, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA 70112, USA.
Circulation. 2011 Aug 2;124(5):589-95. doi: 10.1161/CIRCULATIONAHA.110.009159. Epub 2011 Jul 18.
Observational studies have reported an inverse association between dietary protein intake and blood pressure (BP). We compared the effect of soy protein, milk protein, and carbohydrate supplementation on BP among healthy adults.
We conducted a randomized, double-blind crossover trial with 3 intervention phases among 352 adults with prehypertension or stage 1 hypertension in New Orleans, LA, and Jackson, MS, from September 2003 to April 2008. The trial participants were assigned to take 40 g/d soy protein, milk protein, or carbohydrate supplementation each for 8 weeks in a random order. A 3-week washout period was implemented between the interventions. Three BPs were measured at 2 baseline and 2 termination visits during each of 3 intervention phases with a random-zero sphygmomanometer. Compared with carbohydrate controls, soy protein and milk protein supplementations were significantly associated with -2.0 mm Hg (95% confidence interval -3.2 to -0.7 mm Hg, P=0.002) and -2.3 mm Hg (-3.7 to -1.0 mm Hg, P=0.0007) net changes in systolic BP, respectively. Diastolic BP was also reduced, but this change did not reach statistical significance. There was no significant difference in the BP reductions achieved between soy or milk protein supplementation.
The results from this randomized, controlled trial indicate that both soy and milk protein intake reduce systolic BP compared with a high-glycemic-index refined carbohydrate among patients with prehypertension and stage 1 hypertension. Furthermore, these findings suggest that partially replacing carbohydrate with soy or milk protein might be an important component of nutrition intervention strategies for the prevention and treatment of hypertension.
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00107744.
观察性研究报告称,饮食蛋白质摄入量与血压(BP)呈负相关。我们比较了大豆蛋白、牛奶蛋白和碳水化合物补充剂对健康成年人血压的影响。
我们在新奥尔良和杰克逊进行了一项随机、双盲交叉试验,共有 352 名患有前期高血压或 1 期高血压的成年人参与,试验于 2003 年 9 月至 2008 年 4 月进行。试验参与者被随机分配在 8 周内每天服用 40 克大豆蛋白、牛奶蛋白或碳水化合物补充剂。在干预之间实施了 3 周的洗脱期。在 3 个干预阶段的每一次,使用随机零式血压计在 2 次基线和 2 次终止访问时测量 3 次血压。与碳水化合物对照组相比,大豆蛋白和牛奶蛋白补充剂与收缩压的净变化分别为-2.0mmHg(95%置信区间-3.2 至-0.7mmHg,P=0.002)和-2.3mmHg(-3.7 至-1.0mmHg,P=0.0007)显著相关。舒张压也有所降低,但这一变化没有达到统计学意义。大豆蛋白和牛奶蛋白补充剂在降低血压方面没有显著差异。
这项随机对照试验的结果表明,与高血糖指数精制碳水化合物相比,摄入大豆蛋白和牛奶蛋白均可降低前期高血压和 1 期高血压患者的收缩压。此外,这些发现表明,用大豆蛋白或牛奶蛋白部分替代碳水化合物可能是高血压预防和治疗营养干预策略的重要组成部分。